During the past decade, AZ -VUB Dienst Nefrologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ -VUB Dienst Nefrologie" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AZ -VUB Dienst Nefrologie" are "Hepatitis B" (2 trials). Many other conditions were trialed in "AZ -VUB Dienst Nefrologie" in a lesser frequency.

Most popular intervention types in "AZ -VUB Dienst Nefrologie" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "FENDRIX" (1 trials), "Fendrix vaccine" (1 trials), "Henogen HB vaccine" (1 trials) and "Henogen HBV vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "AZ -VUB Dienst Nefrologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AZ -VUB Dienst Nefrologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in AZ -VUB Dienst Nefrologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AZ -VUB Dienst Nefrologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".